Mycobacterium tuberculosis induces high production of nitric oxide in coordination with production of tumour necrosis factor-α in patients with fresh active tuberculosis but not in MDR tuberculosis

Immunology and Cell Biology

Volumn 82, Issue 4, 2004, Pages 377-382

  Sharma, Sadhna ^a   Sharma, Monika ^a   Roy, Sugata ^a   Kumar, Praveen ^b   Bose, Mridula ^a  

^a UNIVERSITY OF DELHI   (India)

^b RBTB Hospital   (India)

Author keywords

IL 12; M. tuberculosis; MDR TB; Nitric oxide; TNF

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG TUBERCULOSIS; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL;

ADULT; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-12; MALE; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY; TUMOR NECROSIS FACTOR-ALPHA;

ACTINOBACTERIA (CLASS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 4344690369     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0818-9641.2004.01245.x     Document Type: Article

References (26)

1. Dye C, Sceele S, Doblin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, mortality by country. WHO Global Surveillance Monitoring Project. JAMA 1999; 282: 677-86.
2. Pablos-Mendez A, Raviglione MC, Laszlo A et al. Global surveillance for antituberculous drug resistance, 1994-97. N. Engl. J. Med. 1998; 338: 1641-9.
3. Iseman MD, Madsen LA. Drug resistant tuberculosis. Clin. Chest Med. 1989; 10: 341-53.
4. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl Acad. Sci. USA 1997; 94: 5243-8.
5. Chan ED, Chan J, Schulger NW. What is the role of Nitric Oxide in murine and human host defense against tuberculosis? Current knowledge. Am. J. Respir. Cell Mol. Biol. 2001; 25: 606-12.
6. Nathan C, Shiloh MU. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. USA 2000; 97: 8841-8.
7. Chan ED, Winston BW, Uh ST, Wynes MW, Rose DM, Riches DW. Evaluation of the role of mitogen-activated protein kinases in the expression of inducible nitric oxide synthase by IFN-γ and TNF-α in mouse macrophages. J. Immunol. 1999; 162: 415-22.
8. Bonecini-Almeida MG, Chitale S, Boutsikakis I et al. Induction of in vitro human macrophage anti-Mycobacterium tuberculosis activity: requirement for IFN-γ and primed lymphocytes. J. Immunol. 1998; 160: 4490-9.
9. Rockett KA, Brookes R, Udalova I, Vidal V, Hill A, Kwiatkowski D. 1,25-dihydroxyvitamin D3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in human macrophages-like cell line. Infect. Immun. 1998; 66: 5314-21.
10. Aston C, Rom WN, Talbot NT, Reibman J. Early inhibition of mycobacterial growth by human alveolar macrophages is not due to nitric oxide. Am. J. Respir. Crit. Care Med. 1998; 157: 1943-50.
11. Schneemann M, Schoedon G, Hofer S, Blau N, Guerrero L, Schaffner A. Nitric oxide synthase is not constituent of the antimicrobial armature of human mononuclear phagocytes. J. Infect. Dis. 1993; 167: 1358-63.
12. Padgett EL, Bruett SB. Evaluation of nitrite production by human monocyte derived macrophages. Biochem. Biophys. Res. Comm. 1992; 6: 775-81.
13. Murray HW, Teitelbaum RF. L-arginine dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis. 1992; 165: 513-7.
14. Bose M, Farnia P, Sharma S, Chattopadhya D, Saha K. Nitric oxide dependent killing of Mycobacterium tuberculosis by human mononuclear phagocytes from patients with active tuberculosis. Int. J. Immunopathol. Pharmacol. 1999; 12: 69-79.
15. Scudieno DA, Shoemaker RH, Paul KD et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumour cell lines. Cancer Res. 1988; 48: 4827-33.
16. Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 1998; 141: 2407-12.
17. Long R, Light B, Talbot JA. Mycobacteriocidal action of exogenous nitric oxide. Antimicrob. Agents Chemother. 1999; 43: 403-5.
18. Yu K, Mitchell C, Xing Y, Magliozzo RS, Bloom BR, Chan J. Toxicity of nitrogen oxides and related oxidants on mycobacteria: M. tuberculosis is resistant to peroxynitrite anion. Tuber. Lung Dis. 1999; 79: 191-8.
19. Nicholson S, Bonecini-Almeida Mda G, Lapa e Silva JR et al. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 1996; 183: 2293-302.
20. Wang CH, Liu CY, Lin HC, Yu CT, Chung KF, Kuo HP. Increased exhaled nitric oxide in active pulmonary tuberculosis due to inducible NO synthase upregulation in alveolar macrophages. Eur. Respir. J. 1998; 11: 809-15.
21. Rich EA, Torres M, Sada E, Finegan CK, Hamilton BD, Toossi Z. Mycobacterium tuberculosis (MTB) -stimulated production of nitric oxide by human alveolar macrophages and relationship of nitric oxide production to growth inhibition of MTB. Tuber. Lung. Dis. 1997; 78: 247-55.
22. Chan J, Tanaka K, Carroll D, Flynn J, Bloom BR. Effects of nitric oxide synthase inhibitors on murine infection with Mycobacterium tuberculosis. Infect. Immun. 1995; 63: 736-40.
23. Sharma S, Bose M. The role of cytokines in immune response to pulmonary tuberculosis. Asian Pacific J. Allergy Immunol. 2001; 19: 213-9.
24. Flesh IEA, Kaufmann SHE. Role of cytokines in tuberculosis. Immunobiol. 1993; 189: 316-39.
25. Wang CH, Lin HC, Liu CY et al. Upregulation of inducible nitric oxide synthase and cytokine secretion in peripheral blood monocytes from pulmonary tuberculosis patients. Int. J. Tuberc. Lung Dis. 2001; 5: 283-91.
26. Fulton SA, Cross JV, Toossi ZT, Boom WH. Regulation of interleukin-12 by interleukin-10, transforming growth factor-β, tumour necrosis factor-α and interferon-γ in human monocytes infected with Mycobacterium tuberculosis H37Ra. J. Infect. Dis. 1998; 178: 1105-14.